InvestorsHub Logo
Followers 22
Posts 1671
Boards Moderated 0
Alias Born 12/12/2006

Re: None

Tuesday, 10/24/2017 6:00:32 PM

Tuesday, October 24, 2017 6:00:32 PM

Post# of 7256
Today Cantor Fitzgerald Reaffirmed $50.0 Target Price per Share On Revance Therapeutics.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News